Dedicated to Research Since 1993

Global Antipsychotic Drugs Market by Application (Schizophrenia, Bipolar disorder, Unipolar depression, Dementia) by Drug Classification (First-generation, Second-generation, Third generation)– Business Overview, Analysis and Industry Forecast 2017-2023

 Healthcare and Pharmaceuticals

Report Overview

Global Antipsychotic Drugs Market was valued at USD XX Billion in the year 2017. Global Antipsychotic Drugs Market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX Billion by the year 2023. 

North America region holds the highest market share in 2017 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At the country level, U.S, India, and China are the major markets and holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years. North America is expected to dominate the market share, owing to well-established healthcare infrastructure, a better regulatory framework, and government support in the countries of this region.

The Antipsychotic Drugs market is segmented on the basis of brands type, application, and geography. The global antipsychotic drugs market is segmented into three categories based on brands such as First, Second and third generation antipsychotic drugs, of which the first generation was the largest type segment of the Antipsychotic Drugs market in 2017 and is expected to grow with XX% CAGR in coming years.

Based on application, it is classified into Schizophrenia, Bipolar disorder, Dementia, Unipolar Depression and Others. The drugs used in Schizophrenia and psychotic depression are expected to boost the growth of antipsychotic drugs market due to increasing incidences of these two conditions.


            Rise Prevalence of Psychosis and Associated Disorders


            Increase in Cases of Addiction Associated with these Drugs


            Constant Investment in Research and Development


            Patent Expiry of Major Drugs 

Eli Lily (U.S), AstraZeneca (U.K), GlaxoSmithKline (U.K), Johnson & Johnson (U.S), Bristol-Myers Squibb Company (U.S), Pfizer, Inc. (U.S), and Allergan (Dublin) among others are some of the key players in the Global Antipsychotic Drugs Market.

Key Benefits for Stakeholders

Antipsychotic Drugs manufacturers and retailers

Pharmaceutical and healthcare organizations

Industry associations

Government & Regulatory agencies and organizations

By Application


Bipolar disorder

Unipolar depression



Drug classification

First-generation Antipsychotic Drugs

Second-generation Antipsychotic Drugs

Third generation Antipsychotic Drugs

By Region

North America




Key Market Players

Eli Lily



Johnson & Johnson

Bristol-Myers Squibb Company

Pfizer, Inc.


(Another brief information of 13 companies will be provided in the report.)

Research Methodology:

Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –

  1.      Raw Market Data is collected and compared with the Existing in-house Data on a broad front.
  2.      Both Bottom-Up and Top-Down approaches are analyzed for segmenting and estimating measurable aspects of the market.
  3.      To avoid bias, we filter the collected data collected from authenticated sources.
  4.      GMI has a well proven Statistical Modeling System for estimates and forecasts.
  5.      Further, the report findings are validated with the Industry Expert Panel on face to face or telephonic interviews.
  6.      Panelists are approached from Leading Enterprises across the value chain including manufacturers, suppliers, technology providers, domain experts and buyers so as to validate a thorough and balanced market overview.

Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.

Table Of Content

1. Introduction

1.1 Market Vision

       1.1.1 Market Definition

       1.1.2 Market Scope

1.2 Limitations

1.3 Stakeholders

2. Research Methodology

2.1. Research Process

       2.1.1. Secondary Research

    Key Data from Secondary Research

       2.1.2. Primary Research

    Key Data from Primary Research

    Breakdowns of Primary Interviews

2.2. Market Size Estimation

       2.2.1. Bottom-Up Approach

       2.2.2. Top-Down Approach

       2.2.3. Annual Revenue Process

2.3. Data Triangulation 

2.4. Research Assumptions 

       2.4.1. Assumption

3. Executive Summary

4. Market Overview

4.1. Introduction

4.2. Drivers

4.3. Restraints

4.4. Opportunities

4.5. Challenges

4.6. Regulations

4.7. Supply Chain/Value Chain Analysis

4.8. Patent & Standards

5. Industry Trends

5.1. Introduction

5.2. Porter’s Five Forces Analysis

       5.2.1. Threat of New Entrants

       5.2.2. Threat of Substitutes

       5.2.3. Bargaining Power of Buyers

       5.2.4. Bargaining Power of Suppliers

       5.2.5. Intensity of Competitive Rivalry

6. Global Antipsychotic Drugs Market, By application

6.1 Schizophrenia

6.2 Bipolar disorder

6.3 Unipolar depression

6.4 Dementia

6.5 Others

7. Global Antipsychotic Drugs Market, By Drug classification

7.1 First-generation Antipsychotic Drugs

7.2 Second-generation Antipsychotic Drugs

7.3 Third generation Antipsychotic Drugs

8. Geographical Analysis

8.1. Introduction

8.2. North America

       8.2.1. U.S.

       8.2.2. Canada

       8.2.3. Mexico

8.3. Europe

       8.3.1. U.K.

       8.3.2. Germany

       8.3.3. Italy

       8.3.4. France

       8.3.5. RoE

8.4. Asia Pacific

       8.4.1. South Korea

       8.4.2. China

       8.4.3. Japan

       8.4.4. South Korea

       8.4.5. RoAPAC

8.5. RoW

       8.5.1. Latin America

       8.5.2. Middle East and Africa

9. Company Profiles

(Business Overview, Financial Overview, Product write Up, Recent Developments)

9.1 Eli Lily

9.2 AstraZeneca

9.3 GlaxoSmithKline

9.4 Johnson & Johnson

9.5 Bristol-Myers Squibb Company

9.6 Pfizer, Inc.

9.7 Allergan

(Another brief information of 13 companies will be provided in the report.) 

10. Competitive Analysis

10.1. Introduction

10.2. Market Positioning of Key Players

10.3 Competitive Strategies Adopted by Leading Players

        10.3.1. Investments & Expansions

        10.3.2. New Product Launches

        10.3.3. Mergers & Acquisitions

        10.3.4. Agreements, Joint Ventures, and Partnerships

11. Appendix

11.1. Questionnaire

11.2. Available Customizations 

11.3. Upcoming Events (Trade Fair, Exhibitions, Conferences) 

* The list of tables and figures will be provided in the sample report.


No Content Available.



Related Reports